FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Local, systemic and immunologic safety comparison between xe...
Frontiers in veterinary science2023; 10; 1098029; doi: 10.3389/fvets.2023.1098029

Local, systemic and immunologic safety comparison between xenogeneic equine umbilical cord mesenchymal stem cells, allogeneic canine adipose mesenchymal stem cells and placebo: a randomized controlled trial.

Abstract: Mesenchymal stem cells are multipotent cells with a wide range of therapeutic applications, including, among others, tissue regeneration. This work aims to test the safety (EUC-MSC) of intra-articular administration of equine umbilical cord mesenchymal stem cells in young healthy dogs under field conditions following single and repeated administration. This was compared with the safety profile of allogenic canine adipose derived mesenchymal stem cells (CAD-MSC) and placebo in order to define the safety of xenogeneic use of mesenchymal stem cells when administered intra-articular. Twenty-four police working dogs were randomized in three groups in a proportion 1:1:1. EUC-MSCs and CAD-MSCs were obtained from healthy donors and were manufactured following company SOPs and under GMP and GMP-like conditions, respectively, and compliant all necessary controls to ensure the quality of the treatment. The safety of the treatment was evaluated locally, systemically and immunologically. For this purpose, an orthopedic examination and Glasgow test for the assessment of pain in the infiltrated joint, blood tests, clinical examination and analysis of the humoral and cellular response to treatment were performed. No adverse events were detected following single and repeated MSC administration despite both equine and canine MSC generate antibody titres in the dogs. The intra-articular administration of equine umbilical cord mesenchymal stem cells in dogs has demonstrated to be safe.
Copyright © 2023 Punzón, García-Castillo, Rico, Padilla and Pradera.
Get Full Text
Publication Date: 2023-05-17 PubMed ID: 37266387PubMed Central: PMC10229832DOI: 10.3389/fvets.2023.1098029Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study compares the safety of locally injecting stem cells from horse umbilical cords and dog fat tissue into healthy working dogs. The research proved that such treatment showed no adverse effects, although the dogs started to produce antibodies in response to both types of cells.

Introduction

  • The field of regenerative medicine is exponentially expanding, with mesenchymal stem cells (MSCs) being one of the most promising forms of therapy. They have extensive therapeutic potential—particularly in tissue regeneration.
  • This study aimed to assess the safety of a novel treatment involving the intra-articular (within the joint) injection of equine umbilical cord mesenchymal stem cells (EUC-MSCs) into healthy dogs, with repeated administration. This was done under typical field conditions.

Methods

  • To make a meaningful comparison, this EUC-MSC treatment was compared with two others: the current standard treatment using canine adipose (fat) derived MSCs (CAD-MSCs) and a placebo treatment.
  • The researchers used 24 working police dogs randomized in a 1:1:1 ratio to ensure a balanced distribution of subjects across the three treatments.
  • The MSCs were obtained from healthy donors and prepared according to Standard Operating Procedures (SOPs) under Good Manufacturing Practices (GMP) conditions.
  • The effectiveness of the treatment was assessed through local, systemic, and immunological evaluation—we tested on the local area, the full body, and the immune response to treatment.

Results and Discussion

  • They performed extensive tests, such as an orthopedic examination and the Glasgow test for assessing pain in the injected joint. Blood tests, clinical exams, and analysis of the humoral and cellular response to the treatment were also conducted.
  • Remarkably, there were no adverse events following either single or repeated administration of the MSC treatment, which signifies a high level of safety associated with this treatment.
  • In an interesting finding, the study showed that both the equine and canine MSCs triggered the production of antibodies in the dogs. This offers valuable insights into the dogs’ immunological response.
  • Thus, the research convincingly demonstrated that the intra-articular injection of EUC-MSCs in dogs is a safe procedure.

Cite This Article

APA
Punzón E, García-Castillo M, Rico MA, Padilla L, Pradera A. (2023). Local, systemic and immunologic safety comparison between xenogeneic equine umbilical cord mesenchymal stem cells, allogeneic canine adipose mesenchymal stem cells and placebo: a randomized controlled trial. Front Vet Sci, 10, 1098029. https://doi.org/10.3389/fvets.2023.1098029

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 10
Pages: 1098029
PII: 1098029

Researcher Affiliations

Punzón, Eva
  • EquiCord S. L., Alcorcón, Madrid, Spain.
García-Castillo, María
  • EquiCord S. L., Alcorcón, Madrid, Spain.
Rico, Miguel A
  • EquiCord S. L., Alcorcón, Madrid, Spain.
Padilla, Laura
  • LEITAT Technological Center, Barcelona, Spain.
Pradera, Almudena
  • EquiCord S. L., Alcorcón, Madrid, Spain.

Conflict of Interest Statement

EP, MG-C, MR, and AP are employed by EquiCord S.L. EquiCord owns DogStem’s European Marketing Authorisation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 71 references
  1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    doi: 10.1080/14653240600855905pubmed: 16923606google scholar: lookup
  2. Huang S, Leung V, Peng S, Li L, Lu FJ, Wang T, Lu W, Cheung KM, Zhou G. Developmental definition of MSCs: new insights into pending questions.. Cell Reprogram 2011 Dec;13(6):465-72.
    doi: 10.1089/cell.2011.0045pmc: PMC3229822pubmed: 21919705google scholar: lookup
  3. Kim HS, Kim KH, Kim SH, Kim YS, Koo KT, Kim TI, Seol YJ, Ku Y, Rhyu IC, Chung CP, Lee YM. Immunomodulatory effect of canine periodontal ligament stem cells on allogenic and xenogenic peripheral blood mononuclear cells.. J Periodontal Implant Sci 2010 Dec;40(6):265-70.
    doi: 10.5051/jpis.2010.40.6.265pmc: PMC3021166pubmed: 21246016google scholar: lookup
  4. Gugjoo MB, Amarpal, Chandra V, Wani MY, Dhama K, Sharma GT. Mesenchymal Stem Cell Research in Veterinary Medicine.. Curr Stem Cell Res Ther 2018;13(8):645-657.
    doi: 10.2174/1574888X13666180517074444pubmed: 29769009google scholar: lookup
  5. Toh WS, Lai RC, Hui JHP, Lim SK. MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment.. Semin Cell Dev Biol 2017 Jul;67:56-64.
    doi: 10.1016/j.semcdb.2016.11.008pubmed: 27871993google scholar: lookup
  6. Zhao X, Zhao Y, Sun X, Xing Y, Wang X, Yang Q. Immunomodulation of MSCs and MSC-Derived Extracellular Vesicles in Osteoarthritis.. Front Bioeng Biotechnol 2020;8:575057.
    doi: 10.3389/fbioe.2020.575057pmc: PMC7673418pubmed: 33251195google scholar: lookup
  7. Kriston-Pál É, Czibula Á, Gyuris Z, Balka G, Seregi A, Sükösd F, Süth M, Kiss-Tóth E, Haracska L, Uher F, Monostori É. Characterization and therapeutic application of canine adipose mesenchymal stem cells to treat elbow osteoarthritis.. Can J Vet Res 2017 Jan;81(1):73-78.
    pmc: PMC5220603pubmed: 28197017
  8. Brondeel C, Pauwelyn G, de Bakker E, Saunders J, Samoy Y, Spaas JH. Review: Mesenchymal Stem Cell Therapy in Canine Osteoarthritis Research: "Experientia Docet" (Experience Will Teach Us).. Front Vet Sci 2021;8:668881.
    doi: 10.3389/fvets.2021.668881pmc: PMC8169969pubmed: 34095280google scholar: lookup
  9. Gupta PK, Das AK, Chullikana A, Majumdar AS. Mesenchymal stem cells for cartilage repair in osteoarthritis.. Stem Cell Res Ther 2012 Jul 9;3(4):25.
    doi: 10.1186/scrt116pmc: PMC3580463pubmed: 22776206google scholar: lookup
  10. Sasaki A, Mizuno M, Mochizuki M, Sekiya I. Mesenchymal stem cells for cartilage regeneration in dogs.. World J Stem Cells 2019 May 26;11(5):254-269.
    doi: 10.4252/wjsc.v11.i5.254pmc: PMC6545524pubmed: 31171954google scholar: lookup
  11. Lo Monaco M, Merckx G, Ratajczak J, Gervois P, Hilkens P, Clegg P, Bronckaers A, Vandeweerd JM, Lambrichts I. Stem Cells for Cartilage Repair: Preclinical Studies and Insights in Translational Animal Models and Outcome Measures.. Stem Cells Int 2018;2018:9079538.
    doi: 10.1155/2018/9079538pmc: PMC5832141pubmed: 29535784google scholar: lookup
  12. Toupet K, Maumus M, Peyrafitte JA, Bourin P, van Lent PL, Ferreira R, Orsetti B, Pirot N, Casteilla L, Jorgensen C, Noël D. Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice.. Arthritis Rheum 2013 Jul;65(7):1786-94.
    doi: 10.1002/art.37960pubmed: 23553439google scholar: lookup
  13. Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kim YJ, Jo JY, Yoon EJ, Choi HJ, Kwon E. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans.. Stem Cells Dev 2011 Aug;20(8):1297-308.
    doi: 10.1089/scd.2010.0466pubmed: 21303266google scholar: lookup
  14. Plotnikov AN, Shlapakova I, Szabolcs MJ, Danilo P Jr, Lorell BH, Potapova IA, Lu Z, Rosen AB, Mathias RT, Brink PR, Robinson RB, Cohen IS, Rosen MR. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart.. Circulation 2007 Aug 14;116(7):706-13.
    doi: 10.1161/CIRCULATIONAHA.107.703231pubmed: 17646577google scholar: lookup
  15. Wang Y, Han ZB, Ma J, Zuo C, Geng J, Gong W, Sun Y, Li H, Wang B, Zhang L, He Y, Han ZC. A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys.. Stem Cells Dev 2012 Jun 10;21(9):1401-8.
    doi: 10.1089/scd.2011.0441pubmed: 21958114google scholar: lookup
  16. Beggs KJ, Lyubimov A, Borneman JN, Bartholomew A, Moseley A, Dodds R, Archambault MP, Smith AK, McIntosh KR. Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons.. Cell Transplant 2006;15(8-9):711-21.
    doi: 10.3727/000000006783981503pubmed: 17269442google scholar: lookup
  17. Kol A, Wood JA, Carrade Holt DD, Gillette JA, Bohannon-Worsley LK, Puchalski SM, Walker NJ, Clark KC, Watson JL, Borjesson DL. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.. Stem Cell Res Ther 2015 Apr 15;6(1):73.
    doi: 10.1186/s13287-015-0050-0pmc: PMC4446064pubmed: 25888916google scholar: lookup
  18. Vilar JM, Morales M, Santana A, Spinella G, Rubio M, Cuervo B, Cugat R, Carrillo JM. Controlled, blinded force platform analysis of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs.. BMC Vet Res 2013 Jul 2;9:131.
    doi: 10.1186/1746-6148-9-131pmc: PMC3716942pubmed: 23819757google scholar: lookup
  19. Nicpoń J, Marycz K, Grzesiak J, Śmieszek A, Toker ZY. The advantages of autologus adipose derived mesenchymal stem cells (AdMSCs) over the non-steroidal anti-inflammatory drugs (NSAIDs) application for degenerative elbow joint disease treatment in dogs-twelve cases.. Kafkas Univ Vet Fak Derg (2014) 20:345–50.
    doi: 10.9775/kvfd.2013.10105google scholar: lookup
  20. Cabon Q, Febre M, Gomez N, Cachon T, Pillard P, Carozzo C, Saulnier N, Robert C, Livet V, Rakic R, Plantier N, Saas P, Maddens S, Viguier E. Long-Term Safety and Efficacy of Single or Repeated Intra-Articular Injection of Allogeneic Neonatal Mesenchymal Stromal Cells for Managing Pain and Lameness in Moderate to Severe Canine Osteoarthritis Without Anti-inflammatory Pharmacological Support: Pilot Clinical Study.. Front Vet Sci 2019;6:10.
    doi: 10.3389/fvets.2019.00010pmc: PMC6371748pubmed: 30805348google scholar: lookup
  21. Black LL, Gaynor J, Gahring D, Adams C, Aron D, Harman S, Gingerich DA, Harman R. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial.. Vet Ther 2007 Winter;8(4):272-84.
    pubmed: 18183546
  22. Nöth U, Steinert AF, Tuan RS. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy.. Nat Clin Pract Rheumatol 2008 Jul;4(7):371-80.
    doi: 10.1038/ncprheum0816pubmed: 18477997google scholar: lookup
  23. Lin CS, Lin G, Lue TF. Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants.. Stem Cells Dev 2012 Oct 10;21(15):2770-8.
    doi: 10.1089/scd.2012.0176pmc: PMC3806387pubmed: 22621212google scholar: lookup
  24. Ashour RH, Saad MA, Sobh MA, Al-Husseiny F, Abouelkheir M, Awad A, Elghannam D, Abdel-Ghaffar H, Sobh M. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.. Stem Cell Res Ther 2016 Sep 1;7(1):126.
    doi: 10.1186/s13287-016-0386-0pmc: PMC5009659pubmed: 27585525google scholar: lookup
  25. Amann EM, Rojewski MT, Rodi S, Fürst D, Fiedler J, Palmer A, Braumüller S, Huber-Lang M, Schrezenmeier H, Brenner RE. Systemic recovery and therapeutic effects of transplanted allogenic and xenogenic mesenchymal stromal cells in a rat blunt chest trauma model.. Cytotherapy 2018 Feb;20(2):218-231.
    doi: 10.1016/j.jcyt.2017.11.005pubmed: 29223534google scholar: lookup
  26. Gutiérrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, Otero-Ortega L, Fuentes B, Vallejo-Cremades MT, Sanz-Cuesta BE, Díez-Tejedor E. Comparison between xenogeneic and allogeneic adipose mesenchymal stem cells in the treatment of acute cerebral infarct: proof of concept in rats.. J Transl Med 2015 Feb 1;13:46.
    doi: 10.1186/s12967-015-0406-3pmc: PMC4322805pubmed: 25637958google scholar: lookup
  27. Tsai SY, Huang YC, Chueh LL, Yeh LS, Lin CS. Intra-articular transplantation of porcine adipose-derived stem cells for the treatment of canine osteoarthritis: A pilot study.. World J Transplant 2014 Sep 24;4(3):196-205.
    doi: 10.5500/wjt.v4.i3.196pmc: PMC4208083pubmed: 25346893google scholar: lookup
  28. Punzón E, Salgüero R, Totusaus X, Mesa-Sánchez C, Badiella L, García-Castillo M, Pradera A. Equine umbilical cord mesenchymal stem cells demonstrate safety and efficacy in the treatment of canine osteoarthritis: a randomized placebo-controlled trial.. J Am Vet Med Assoc 2022 Oct 4;260(15):1947-1955.
    doi: 10.2460/javma.22.06.0237pubmed: 36198051google scholar: lookup
  29. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.. Stem Cells 2006 May;24(5):1294-301.
    doi: 10.1634/stemcells.2005-0342pubmed: 16410387google scholar: lookup
  30. Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.. Int J Mol Med 2014 Sep;34(3):695-704.
    doi: 10.3892/ijmm.2014.1821pmc: PMC4121354pubmed: 24970492google scholar: lookup
  31. Schnabel LV, Fortier LA, McIlwraith CW, Nobert KM. Therapeutic use of stem cells in horses: which type, how, and when?. Vet J 2013 Sep;197(3):570-7.
    doi: 10.1016/j.tvjl.2013.04.018pubmed: 23778257google scholar: lookup
  32. Nagamura-Inoue T, He H. Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility.. World J Stem Cells 2014 Apr 26;6(2):195-202.
    doi: 10.4252/wjsc.v6.i2.195pmc: PMC3999777pubmed: 24772246google scholar: lookup
  33. Sultana T, Lee S, Yoon HY, Lee JI. Current Status of Canine Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Veterinary Medicine.. Stem Cells Int 2018;2018:8329174.
    doi: 10.1155/2018/8329174pmc: PMC6079340pubmed: 30123294google scholar: lookup
  34. Crisostomo PR, Wang M, Wairiuko GM, Morrell ED, Terrell AM, Seshadri P, Nam UH, Meldrum DR. High passage number of stem cells adversely affects stem cell activation and myocardial protection.. Shock 2006 Dec;26(6):575-80.
    doi: 10.1097/01.shk.0000235087.45798.93pubmed: 17117132google scholar: lookup
  35. Smith JR, Pfeifer K, Petry F, Powell N, Delzeit J, Weiss ML. Standardizing Umbilical Cord Mesenchymal Stromal Cells for Translation to Clinical Use: Selection of GMP-Compliant Medium and a Simplified Isolation Method.. Stem Cells Int 2016;2016:6810980.
    doi: 10.1155/2016/6810980pmc: PMC4757747pubmed: 26966439google scholar: lookup
  36. Carrade DD, Borjesson DL. Immunomodulation by mesenchymal stem cells in veterinary species.. Comp Med 2013 Jun;63(3):207-17.
    pmc: PMC3690426pubmed: 23759523
  37. Morton CM, Reid J, Scott EM, Holton LL, Nolan AM. Application of a scaling model to establish and validate an interval level pain scale for assessment of acute pain in dogs.. Am J Vet Res 2005 Dec;66(12):2154-66.
    doi: 10.2460/ajvr.2005.66.2154pubmed: 16379662google scholar: lookup
  38. Reid J, Nolan AM, Hughes JML, Lascelles D, Pawson P, Scott EM. Development of the short-form Glasgow composite measure pain scale (CMPS-SF) and derivation of an analgesic intervention score.. Anim Welf (2007) 16:97–104.
    doi: 10.1017/S096272860003178Xgoogle scholar: lookup
  39. Kornicka K, Szłapka-Kosarzewska J, Śmieszek A, Marycz K. 5-Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy.. J Cell Mol Med 2019 Jan;23(1):237-259.
    doi: 10.1111/jcmm.13914pmc: PMC6307768pubmed: 30370650google scholar: lookup
  40. Bourebaba L, Bedjou F, Röcken M, Marycz K. Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation.. Stem Cell Res Ther 2019 Jun 18;10(1):178.
    doi: 10.1186/s13287-019-1292-zpmc: PMC6582509pubmed: 31215461google scholar: lookup
  41. Carrade Holt DD, Wood JA, Granick JL, Walker NJ, Clark KC, Borjesson DL. Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source.. Stem Cells Dev 2014 Jun 1;23(11):1258-65.
    doi: 10.1089/scd.2013.0537pubmed: 24438346google scholar: lookup
  42. Van Pham P, Bich N, Phan N. Umbilical cord-derived stem cells (ModulatistTM) show strong immunomodulation capacity compared to adipose tissue-derived or bone marrow-derived mesenchymal stem cells.. Biomed Res Ther (2016) 3:29.
    doi: 10.7603/s40730-016-0029-1google scholar: lookup
  43. Tuffs SW, James DBA, Bestebroer J, Richards AC, Goncheva MI, O'Shea M, Wee BA, Seo KS, Schlievert PM, Lengeling A, van Strijp JA, Torres VJ, Fitzgerald JR. The Staphylococcus aureus superantigen SElX is a bifunctional toxin that inhibits neutrophil function.. PLoS Pathog 2017 Sep;13(9):e1006461.
    doi: 10.1371/journal.ppat.1006461pmc: PMC5589267pubmed: 28880920google scholar: lookup
  44. Maki CB, Beck A, Wallis CCC, Choo J, Ramos T, Tong R, Borjesson DL, Izadyar F. Intra-articular Administration of Allogeneic Adipose Derived MSCs Reduces Pain and Lameness in Dogs With Hip Osteoarthritis: A Double Blinded, Randomized, Placebo Controlled Pilot Study.. Front Vet Sci 2020;7:570.
    doi: 10.3389/fvets.2020.00570pmc: PMC7489271pubmed: 33110913google scholar: lookup
  45. Peeters CM, Leijs MJ, Reijman M, van Osch GJ, Bos PK. Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review.. Osteoarthritis Cartilage 2013 Oct;21(10):1465-73.
    doi: 10.1016/j.joca.2013.06.025pubmed: 23831631google scholar: lookup
  46. Mokbel A, El-Tookhy O, Shamaa AA, Sabry D, Rashed L, Mostafa A. Homing and efficacy of intra-articular injection of autologous mesenchymal stem cells in experimental chondral defects in dogs.. Clin Exp Rheumatol 2011 Mar-Apr;29(2):275-84.
    pubmed: 21385540
  47. Mokbel AN, El Tookhy OS, Shamaa AA, Rashed LA, Sabry D, El Sayed AM. Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model.. BMC Musculoskelet Disord 2011 Nov 15;12:259.
    doi: 10.1186/1471-2474-12-259pmc: PMC3232438pubmed: 22085445google scholar: lookup
  48. Kim YS, Kim YI, Koh YG. Intra-articular injection of human synovium-derived mesenchymal stem cells in beagles with surgery-induced osteoarthritis.. Knee 2021 Jan;28:159-168.
    doi: 10.1016/j.knee.2020.11.021pubmed: 33385696google scholar: lookup
  49. Hahn G. VICH GL43 Target Animal Safety: Pharmaceuticals.. London, 22 September 2008 Doc. Ref. EMEA/CVMP/VICH/393388/2006 (2009).
  50. European Medicines Agency. VICH GL44 Target Animal Safety for Veterinary Live and Inactivated Vaccines.. London, 22 September 2008 Doc. Ref. EMEA/CVMP/VICH/359665/2005 (2008).
  51. European Medicines Agency. Stem Cell-Based Products for Veterinary Use: Specific Question on Target Animal Safety Addressed by CVMP/ADVENT.. London: European Medicines Agency; (2020)..
  52. Shah K, Drury T, Roic I, Hansen P, Malin M, Boyd R, Sumer H, Ferguson R. Outcome of Allogeneic Adult Stem Cell Therapy in Dogs Suffering from Osteoarthritis and Other Joint Defects.. Stem Cells Int 2018;2018:7309201.
    doi: 10.1155/2018/7309201pmc: PMC6046133pubmed: 30050578google scholar: lookup
  53. Sanabria-de la Torre R, Quiñones-Vico MI, Fernández-González A, Sánchez-Díaz M, Montero-Vílchez T, Sierra-Sánchez Á, Arias-Santiago S. Alloreactive Immune Response Associated to Human Mesenchymal Stromal Cells Treatment: A Systematic Review.. J Clin Med 2021 Jul 5;10(13).
    doi: 10.3390/jcm10132991pmc: PMC8269175pubmed: 34279481google scholar: lookup
  54. Berglund AK, Fortier LA, Antczak DF, Schnabel LV. Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells.. Stem Cell Res Ther 2017 Dec 22;8(1):288.
    doi: 10.1186/s13287-017-0742-8pmc: PMC5741939pubmed: 29273086google scholar: lookup
  55. Rosa GDS, Krieck AMT, Padula ET, Stievani FC, Rossi MC, Pfeifer JPH, Basso RM, Braz AMM, Golim MA, Alves ALG. Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration.. Front Immunol 2022;13:871216.
    doi: 10.3389/fimmu.2022.871216pmc: PMC9091817pubmed: 35572507google scholar: lookup
  56. Margiana R, Markov A, Zekiy AO, Hamza MU, Al-Dabbagh KA, Al-Zubaidi SH, Hameed NM, Ahmad I, Sivaraman R, Kzar HH, Al-Gazally ME, Mustafa YF, Siahmansouri H. Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review.. Stem Cell Res Ther 2022 Jul 28;13(1):366.
    doi: 10.1186/s13287-022-03054-0pmc: PMC9330677pubmed: 35902958google scholar: lookup
  57. Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, Alcayaga-Miranda F, González PL, Muse E, Khoury M, Figueroa FE, Espinoza F. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.. Stem Cells Transl Med 2019 Mar;8(3):215-224.
    doi: 10.1002/sctm.18-0053pmc: PMC6392367pubmed: 30592390google scholar: lookup
  58. Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.. Gut 2009 Jul;58(7):929-39.
    doi: 10.1136/gut.2008.168534pubmed: 19136511google scholar: lookup
  59. Zhou B, Yuan J, Zhou Y, Ghawji M Jr, Deng YP, Lee AJ, Lee AJ, Nair U, Kang AH, Brand DD, Yoo TJ. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.. Clin Immunol 2011 Dec;141(3):328-37.
    doi: 10.1016/j.clim.2011.08.014pubmed: 21944669google scholar: lookup
  60. Choi EW, Shin IS, Park SY, Park JH, Kim JS, Yoon EJ, Kang SK, Ra JC, Hong SH. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation.. Arthritis Rheum 2012 Jan;64(1):243-53.
    doi: 10.1002/art.33313pubmed: 21904997google scholar: lookup
  61. Garcia-Pedraza E, de Miguel AG, Gomez de Segura IA, Pérez AP. Immunological safety assessment of a single and repeated intra-articular administration of xenogeneic equine umbilical cord mesenchymal stem cells under field conditions in young healthy dogs: a randomized double-blind placebo-controlled study.. Res Vet Sci Med (2022) 2:2.
    doi: 10.25259/RVSM_3_2021google scholar: lookup
  62. Van Hecke L, Magri C, Duchateau L, Beerts C, Geburek F, Suls M, Da Dalt L, Patruno M, Saunders J, Broeckx SY, Depuydt E, Spaas JH. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.. Vet Immunol Immunopathol 2021 Sep;239:110306.
    doi: 10.1016/j.vetimm.2021.110306pubmed: 34365135google scholar: lookup
  63. Depuydt E, Broeckx SY, Chiers K, Patruno M, Da Dalt L, Duchateau L, Saunders J, Pille F, Martens A, Van Hecke L, Spaas JH. Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries.. Front Vet Sci 2021;8:789293.
    doi: 10.3389/fvets.2021.789293pmc: PMC8907452pubmed: 35281431google scholar: lookup
  64. Kalaszczynska I, Ferdyn K. Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance.. Biomed Res Int 2015;2015:430847.
    doi: 10.1155/2015/430847pmc: PMC4377382pubmed: 25861624google scholar: lookup
  65. Gershwin LJ, Netherwood KA, Norris MS, Behrens NE, Shao MX. Equine IgE responses to non-viral vaccine components.. Vaccine 2012 Dec 14;30(52):7615-20.
    doi: 10.1016/j.vaccine.2012.10.029pubmed: 23088888google scholar: lookup
  66. Mogues T, Li J, Coburn J, Kuter DJ. IgG antibodies against bovine serum albumin in humans--their prevalence and response to exposure to bovine serum albumin.. J Immunol Methods 2005 May;300(1-2):1-11.
    doi: 10.1016/j.jim.2005.01.022pubmed: 15890355google scholar: lookup
  67. Atkinson MA, Bowman MA, Kao KJ, Campbell L, Dush PJ, Shah SC, Simell O, Maclaren NK. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes.. N Engl J Med 1993 Dec 16;329(25):1853-8.
    doi: 10.1056/NEJM199312163292505pubmed: 8247037google scholar: lookup
  68. Passero LF, Carvalho AK, Bordon ML, Bonfim-Melo A, Carvalho K, Kallás EG, Santos BB, Toyama MH, Paes-Leme A, Corbett CE, Laurenti MD. Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation.. Parasit Vectors 2012 Mar 30;5:64.
    doi: 10.1186/1756-3305-5-64pmc: PMC3342111pubmed: 22463817google scholar: lookup
  69. Martin MD, Badovinac VP. Defining Memory CD8 T Cell.. Front Immunol 2018;9:2692.
    doi: 10.3389/fimmu.2018.02692pmc: PMC6255921pubmed: 30515169google scholar: lookup
  70. Baran J, Kowalczyk D, Ozóg M, Zembala M. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation.. Clin Diagn Lab Immunol 2001 Mar;8(2):303-13.
    doi: 10.1128/CDLI.8.2.303-313.2001pmc: PMC96054pubmed: 11238213google scholar: lookup
  71. Simpson JW. Diet and large intestinal disease in dogs and cats.. J Nutr 1998 Dec;128(12 Suppl):2717S-2722S.
    doi: 10.1093/jn/128.12.2717Spubmed: 9868250google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.